1:01 PM
 | 
Mar 02, 2018
 |  BC Week In Review  |  Company News  |  Deals

BenevolentAI acquires facility at Babraham campus

BenevolentAI (London, U.K.) acquired a drug discovery and development facility on the Babraham Research Campus (Cambridge, U.K.) for an undisclosed amount....

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >